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ABSTRACT 
 
Carbon nanotubes (CNTs) are at present being considered as potential nanovectors with the 
ability to deliver therapeutic cargoes into living cells. Previous studies established the ability of 
CNTs to enter cells and their therapeutic utility, but an appreciation of global intracellular 
trafficking associated with their cellular distribution has yet to be described. Despite the many 
aspects of the uptake mechanism of CNTs being studied, only a few studies have 
investigated internalization and fate of CNTs inside cells in detail. In the present study, 
intracellular localization and trafficking of RNA-wrapped, oxidized double-walled CNTs 
(oxDWNT-RNA) is presented. Fixed cells, previously exposed to oxDWNT-RNA, were 
subjected to immunocytochemical analysis using antibodies specific to proteins implicated in 
endocytosis; moreover cell compartment markers and pharmacological inhibitory conditions 
were also employed in this study. Our results revealed that an endocytic pathway is involved 
in the internalization of oxDWNT-RNA. The nanotubes were found in clathrin-coated vesicles, 
after which they appear to be sorted in early endosomes, followed by vesicular maturation, 
become located in lysosomes. Furthermore, we observed co-localization of oxDWNT-RNA 
with the small GTP-binding protein (Rab11), involved in their recycling back to the plasma 
membrane via endosomes from the trans-golgi network. 
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1 Introduction 
The mechanisms that control cellular uptake and 
release of carbon nanotubes (CNTs) are currently 
poorly understood. So far, besides the 
demonstration of the ability of CNTs to enter and 
penetrate cell membranes [1-4], the uptake 
mechanism is still debated and may involve more 
than one process. Indeed, Kam et al. and Jin et al. 
reported that protein or single-stranded 
oligonucleotide-modified CNTs could enter cells by 
means of endocytosis [5, 6]. In contrast, Kostarelos et 
al. suggested an energy-independent non-endocytic 
mechanism to be involved in the insertion and 
diffusion of CNTs through different cellular barriers 
[2].  
Endocytosis is a frequent cellular event that 
transfers extracellular or membrane-bound cargoes, 
such as nutrients, from the plasma membrane into 
the cell interior by vesicular transport. In this 
process, endocytic vesicles form invaginations of 
the plasma membrane that subsequently pinch off, 
move internally, and fuse with other endocytic 
vesicles to form the early endosomal compartment. 
The endocytic process may involve so-called 
clathrin-coated pits (i.e., associated with a 
clathrin-dependent process). Clathrin forms a 
complex network in the form of a lattice that is built 
up to form a coat. Alternatively, there may be 
clathrin-independent endocytotic processes 
involved in cellular trafficking. The early endosome 
is the major sorting station in the endocytic 
pathways. From this organelle, material can be 
directed toward the pathway of recycling to the 
plasma membrane, to subsequent endocytic 
compartments and to regulated secretory vesicles 
[7]. Transferrin for example, a monomeric iron 
transporting serum glycoprotein, is processed in the 
late endosome, after which the transferrin receptors 
are recycled by a recycling endosome [8]. The 
recycling endosome is typically less acidic (pH 
6.4-6.5) than the sorting endosome (pH 6.0) and 
exhibits a pericentriolar localization [9]. Late 
endosomes contain active degradative enzymes; 
however, these are more concentrated in the 
lysosomes. The transfer of material between late 
endosomes and lysosomes appears to be a direct 
fusion event that results in a transient hybrid 
organelle [10].  
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Each step in endocytosis is independently regulated 
by the interaction of multiple proteins. These 
include several small GTP-binding proteins of the 
Rab family. These proteins have been particularly 
examined because of their effectiveness as 
molecular markers for various types of endosomes. 
Rab5, an example of such GTPase-associated 
activity [11], regulates the rate of 
clathrin-dependent endocytosis at the plasma 
membrane and can be used as a marker for early 
sorting endosomes in addition to or in conjunction 
with the transferrin receptor. Rab11 localizes to a 
pericentriolar subpopulation of recycling 
endosomes [12]. It is pertinent to point out that the 
process of endocytosis is a complex process that has 
yet to be completely defined despite significant 
progress in understanding its various components.   
Identification of the mode by which CNTs move 
between cellular compartments after their 
internalization, and the sites in which they localize 
has been thus far been accomplished by simple 
staining of lysosomes by pH-dependent markers 
(e.g. LysoTracker® red) [5, 13], by Transmission 
electron microscopy (TEM) [13-15], or by 
pharmacological inhibition of the endocytic 
pathway [2, 5]. Kam et al. [5] were the first to 
describe an energy-dependent mechanism. In their 
studies clathrin-mediated endocytosis was proven 
by experiments carried out at inhibitory conditions, 
such as presence of sucrose and potassium-depleted 
medium, which revealed a significantly reduced 
level of CNT uptake. Using TEM, Yehia et al. 2007 
observed that single-walled carbon nanotubes 
(SWNTs) dispersed in medium were endocytosed 
and localized in the plasma membrane, cytoplasm, 
endosomes, lysosomes and golgi bodies [16]. A 
similar methodology was used by Mu et al. 2009, 
who proposed a working model for cell uptake of 
multi-walled carbon nanotubes (MWNTs) modified 
by carboxylation or amidation, using TEM imaging 
[15]. In their model CNTs were not only 
internalized via endocytic pathways, but also 
through membrane penetration, depending on 
whether CNTs were present as bundles or highly 
dispersed single CNTs, respectively [15].  After 
both internalization via endocytosis or membrane 
penetration, CNTs were found in lysosomes, 
followed by their extrusion [15]. However, no data 
were presented on the mechanism of exocytosis. Jin 
et al. 2009 presented the first evidence for exocytosis 
of CNTs, which was found to closely match the 
endocytic rate [13]. Furthermore, a study in our 
group demonstrated the time-dependent loss of 
CNTs by cells [4]. 
In contrast to the endocytic pathway, Lacerda et al. 
reported for the first time that membrane 
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penetration of CNTs (SWNTs modified via 
cycloaddition) can lead to their accumulation in the 
perinuclear region of mammalian cells [17]. In 
addition, another study performed by Zhou et al. in 
2010 also showed an endocytosis-independent 
mechanism for non-covalently modified SWNTs 
[18]. In their studies, incubations at 4 °C and in the 
presence of sodium azide (NaN3) were carried out, 
which failed to prevent CNTs from being 
internalized.  
In spite of the considerable effort to elucidate the 
uptake mechanism of CNTs and their intracellular 
localization, an appreciation of global intracellular 
trafficking has yet to be clarified. Herein we attempt 
to complete this study using organelle-specific 
markers to describe and to identify the mechanisms 
through which CNTs are transported as they enter 
and eventually efflux from in vitro-cultured human 
prostate cancer cells. 
 
2 Results and discussion 
DWNT cellular uptake and release has been 
previously demonstrated by our group using 
Raman spectroscopy [4]. However, it is also 
imperative to understand their intracellular route 
and subcellular localizations during their transit 
through cells. Hence, this study presents a detailed 
methodology using confocal microscopy in 
combination with organelle-specific markers to 
examine the intracellular distribution of CNTs. In 
addition, pathway-inhibitory drugs were used to 
identify major processes through which CNTs 
traffic as they enter and eventually efflux from cells. 
For this purpose, fluorescently labelled 
RNA-wrapped oxDWNTs were employed.  
  
 
2.1 Characterization of CNT complexes 
CNT complexes were characterized using 
microscopic techniques, in particular atomic force 
microscopy (AFM) and TEM. Figure 1 (a) depicts an 
AFM scan over a surface of 
fluorescein-RNA-wrapped oxidized DWNTs 
(oxDWNT-RNA-FS). Furthermore, the TEM image 
in Fig. 1 (b) depicts individualized CNTs with 
noticeable two-wall characteristics of DWNTs.  
Raman spectroscopy is a useful tool for the 
identification of CNTs in a sample.  Figure 1 (c) 
exhibits Raman spectra of pristine DWNTs and 
oxDWNT-RNA-FS, showing the characteristic 
Raman features. The first visible peaks are the 
Radial breathing modes (RBMs), caused by uniaxial 
vibrations, and depending linearly on the nanotube 
diameter; these can be found between 150-300 cm-1.  
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The RBM is then followed by the disorder-induced 
D-band between 1250 and 1450 cm-1, the tangential 
mode (or G-band), which is caused by stretching 
along the C-C bonds of graphene, between 
1590-1600 cm-1 [19-21], and finally the G’-band, a 
two-phonon mode ~2700 cm-1 away from the 
excitation wavelength [19]. The spectra in Fig. 1 (c) 
demonstrate that the D-band increases during the 
oxidation process; nevertheless the D/G ratio is 
overall still rather low due to the preservation of the 
structure of the inner tube. 
Figure 1 (d) exhibits the Raman signal of cells 
exposed to oxDWNT-RNA-FS and cells as a control. 
To determine if cells internalized the full complex 
of oxDWNTs, RNA and fluorescein, the same slides 
that were used for fluorescent microscopy were 
used for Raman spectroscopy. The results (Fig. 1 
(d)) show that the G-band, which is a characteristic 
signature band for CNTs, can be clearly observed in 
the Raman spectrum of cells exposed to 
oxDWNT-RNA-FS, thus confirming successful 
cellular uptake. Furthermore, we have shown in an 
independent study by our group based on Raman 
spectroscopy that RNA-wrapped oxidized DWNTs 
are internalized and released by cells in a 
time-dependent manner [4].  In particular, cells 
were exposed to CNTs for 3 hours, corresponding 
with maximal intake, after which CNTs were 
removed from the surrounding medium and the 
release of CNTs from the cells monitored for further 
21 hours. The study showed that CNT were 
released progressively over this time frame up until 
the end point of the experiment (24 hours), when no 
CNT-signal could be measured any longer inside 
the cells [4].  
The stability of oxidized and RNA-wrapped CNTs 
in biological fluids, as well as their cytotoxicity, has 
also been previously examined in our group [22]. In 
that study it was shown that oxidized CNTs are 
relatively stable in cellular growth medium and that 
additional wrapping with RNA further increased 
their stability in human plasma. Moreover, it was 
found that cells incubated with oxidized, 
RNA-wrapped CNTs were 75 % viable [22]. 
Although RNA-wrapping is potentially prone to 
degradation in cellular growth medium or the cell 
interior, it was demonstrated by others that 
siRNA-wrapped CNTs readily enter cells and that 
the siRNA remains biological active in the cell even 
in the presence of serum [23], which is very likely 
due to the fact that CNTs can protect 
single-stranded nucleic acids from enzymatic 
cleavage and intracellular interference from nucleic 
acid binding proteins [24]. 
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Figure 1: Characterization of CNT complexes. AFM (a) and 
TEM (b) images of fluorescently labelled RNA-wrapped 
oxidized DWNTs (oxDWNT-RNA-FS). c) Raman spectra of 
pristine DWNTs and oxDWNT-RNA-FS. The ratio D/G band 
has increased for oxDWNT-RNA-FS samples due to acid 
oxidation. d) Raman spectroscopy of cells exposed to 
oxDWNT-RNA-FS and control (cells only).  
 
 
2.2 Cellular internalization of CNT complexes  
Confocal microscopy was used to demonstrate the 
internalization of fluorescently labelled CNTs. PC3 
human prostate cancer cells were incubated with 30 
µg/mL of oxDWNT-RNA-FS for 2 hours. This 
incubation period was chosen based on previous 
papers on endo- and exocytosis of carbon 
nanotubes, for example by Jin et al., who observed 
maximal cellular uptake of CNTs between 1 and 2 
hours [13]. Subsequently, cells were fixed to prevent 
morphologic changes and inhibit further natural 
cellular transport, which “traps” CNTs in the 
various cellular compartments, in which they are 
located at the time. This provides a snapshot of the 
intracellular distribution of CNTs after 
internalization and release have reached a steady 
state: while some CNTs are just being internalized, 
others are already being sorted in lysosomes, or 
even  exocytosed.  
Figure 2 reveals that incubation of PC3 human 
prostate cancer cells with oxDWNT-RNA-FS 
produced readily detectable fluorescence in the 
cytoplasm  (green) in the same plane than the 
nucleus, but not in the nucleus itself 
(counterstained in blue). The cytoskeleton, which is 
involved in coordinating the organization and 
dynamics of intracellular architecture and therefore 
relevant to the further understanding of membrane 
trafficking was stained with phalloidin (red). Cell 
morphology appeared regular after exposure to 
CNTs and inhibitory drugs, and no obvious signs of 
artefactual cellular damage or associated toxicity 
with the procedures used throughout this work 
were observed.  
 8 
To determine the cellular compartments in which 
CNT complexes localize and traffic between, 
organelle-specific antibodies were employed. After 
fixation to prevent morphological changes, cells 
were incubated with primary antibodies specific to 
certain proteins (e.g. clathrin) and then a 
fluorescently labeled secondary antibody was 
employed specific to the source of the primary 
antibody (e.g. rabbit).   
The internalization via the endocytic route involves 
a cascade of intracellular events, with different 
vesicles and regulators. The observation of CNT 
complexes in intracellular endosome-like structures 
(Fig. 2) suggested that an endocytic pathway was 
involved in the internalization of the complexes. 
Therefore, it was decided to use markers such as 
clathrin and caveolin involved in the first step of 
endocytosis, invagination of the cell membrane, to 
elucidate which endocytosis mechanism in 
particular is responsible for CNT uptake. 
Clathrin-mediated endocytosis is characterized by 
membrane-bound vesicles inside a coat composed 
primarily of the fibrous protein clathrin. In contrast, 
caveolae are plasma membrane invaginations that 
are enriched in cholesterol and sphingolipids. In 
addition, these invaginations also accumulate 
special cholesterol-binding proteins, termed 
caveolins, on the cytosolic face of vesicles [25-28]. 
Certain ligands, which are internalized via 
caveolae, are likely to be delivered to a special 
endosomal compartment referred to as a 
“caveosome” [29]. Caveosomes containing 
caveolins do not transport/co-localize transferrin, 
lack EEA1 and other early endosomal markers, 
have neutral pH, and can act as sorting stations [26]. 
Figure 2 (c) shows co-localization of the CNT 
complexes (green) with clathrin (red); but no 
co-localization with caveolin (Fig. 2 (b)).  
Generally, newly formed plasma 
membrane-derived endocytic vesicles lose their 
clathrin coat and fuse with each other or with 
pre-existing compartments known as sorting 
endosomes [30, 31]. The first endosomal 
compartment, the sorting or early endosome, has a 
role in sorting the cargo for further transport. The 
early endosome can be identified using an early 
endosome antigen (EEA1) in combination with a 
fluorescent secondary antibody. Our data show that 
CNT complexes are closely associated with this 
location, as seen via co-localization studies of CNT 
complexes (green) with EEA1 (red) (Fig. 2 (d)).  
The drop in the pH within the sorting endosome 
dissociates many ligands from their receptor, 
allowing those receptors to be recycled back to the 
plasma membrane. As previously described, small 
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GTPases have emerged as central regulators of 
vesicle budding, motility and fusion. One of these 
proteins is Rab 4, involved in the recycling back to 
the plasma membrane from the early endosome.  
However, our results suggest that Rab 4 does not 
have a function in the trafficking of CNT complexes 
through the cell, as no co-localization was observed 
(Fig. 2 (e)). 
Maturation of sorting endosomes into late 
endosomes or multivesicular bodies is coincidental 
with a drop of the pH. The endosome becomes 
incapable to commit further fusion with vesicles 
from the cell surface or other sorting endosomes, 
thus preventing new cargoes and receptors from 
being inadvertently degraded by ‘joining’ a late 
endosome as it matures into/fuses with a lysosome 
[27]. The lysosome can be identified using 
antibodies for lysosome membrane proteins (LMP). 
LMPs reside mainly in the lysosomal limiting 
membrane and have diverse functions, including 
acidification of the lysosomal lumen, protein import 
from the cytosol, membrane fusion and transport of 
degradation products to the cytoplasm. The most 
abundant LMPs are the lysosome-associated 
membrane protein 1 (LAMP1), LAMP2, lysosomal 
integral membrane protein 2 (LIMP2) and the 
tetraspanin CD63 [28]. As demonstrated in Fig. 2 (f), 
a high level of co-localization was observed with 
LAMP2 (selected for our co-localization studies), 
thus indicating that CNT complexes end up in the 
lysosomes after being endocytosed. 
The recycling endosome not only allows for the 
recycling of plasma membrane components (a 
branch of the pathway that might need to be 
avoided in the context of drug delivery) but also 
enables the cell to traffic molecules back to the 
trans-golgi network (TGN/Golgi) [29]. Again, Rab 
proteins have been found to regulate this transport, 
especially the Rab 11 GTPase complex. Figure 2 (g) 
shows co-localization of Rab11 and the CNT 
complexes, indicating that they reach the vesicles 
from the secretory pathway and are delivered by 
Rab11-positive vesicles. The trans-golgi trafficking, 
in which Rab 11 is involved may be further 
validated using antibodies for the golgi97 protein, 
which localizes on the trans side of the golgi 
apparatus. It is believed to participate in the 
trafficking of vesicles between the golgi stacks and 
the trans-golgi network [32]. This additional 
analysis, however, exceeded the scope of this paper. 
In addition to co-localization with a clathrin-specific 
antibody, CNT complexes also co-localized with 
transferrin (Figure 2h). Transferrin is a monomeric 
serum glycoprotein that binds iron. After its 
recognition at the cell surface by transferrin 
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receptors, transferrin is internalized via 
clathrin-dependent endocytosis. Inside endosomes, 
the acidic environment favours dissociation of iron 
from the transferrin. After sorting in late 
endosomes, transferrin then reaches the golgi 
apparatus and is subsequently recycled back to the 
plasma membrane. The co-localization of CNTs 
with this protein further confirms that they are 
internalized via clathrin-dependent endocytosis and 
that they undergo sorting in late endosomes.  
Fluorescent microscopy can furthermore be used as 
a semi-quantitative estimate of the pH in endocytic 
structures in cell culture models by staining with 
pH-sensitive dyes, such as the LysoTracker® dyes. 
This dye stains acidic compartments in live cells, in 
particular the lysosomes. Thus, in combination with 
LAMP2 antibody staining it provides further 
confirmation of the sequestration of CNT 
complexes in lysosomes. As demonstrated in Fig. 2 
(i), there is an overlap between LysoTracker® (red) 
and CNT complexes (green), indicating that the 
CNT complexes are located in an acidic 
compartment. A more detailed analysis including 
co-localization profiles of selected regions can be 
found in Fig. S-2 in the Electronic Supplementary 
Material (ESM). 
It is important to note that confocal microscopy 
does not provide sufficient resolution to observe 
single nanotubes, which have been shown to traffic 
within cells in an entirely different fashion (bundles 
are mainly taken up by endocytosis, whereas single 
nanotubes can pierce though the membrane of the 
cell and also those of intracellular organelles) [15, 
18]. In addition, cellular uptake of CNTs is strongly 
influenced by the type of functionalization used. 
While the surface charge of CNTs (i.e. carboxylated 
(-) and amine-terminated (+) CNTs) did not seem to 
have an effect on cellular uptake due to heavy 
protein coating leading to compensation of the 
surface charges [15], it has been observed that the 
attachment of a large molecule, for example the 
protein bovine serum albumin (BSA), can direct 
cellular uptake towards endocytosis [18].
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Figure 2: Subcellular distribution of CNT complexes in PC3 cells. Cells were incubated with 30 µg/mL of oxDWNT-RNA-FS for 2 
hours. a) Cells stained for presence of actin filaments (red) with Alexa Fluor® 546 Phalloidin and with TO-PRO®-3 for nuclei (blue) 
prior to being imaged for CNT complex accumulation (green). b-i) Co-localization of CNT complexes (green) with antibody-specific 
and compartmental markers (red) in PC3 cells. Co-localization was observed for clathrin-positive vesicles (c); EEA1-positive early 
endosomal vesicles (d); Lamp2-positive lysosomes, (f); Rab11-positive recycling endosomes (g); transferrin (h); and LysoTracker® 
red (i). Yellow colour (arrows) indicates cell compartments positive for both CNT complexes and organelle markers. Counterstaining 
was not observed for caveolin (b) and Rab 4 (e).  
 
2.3 Effect of pathway inhibitory drugs on 
CNT-complexes localization  
A systematic analysis of intracellular transport 
pathways is readily achieved by analysing the 
effects of inhibiting one or more transport 
processes. A widely used method for inhibiting 
transport is to apply a temperature block to cells 
[30]. Most transport processes, including 
clathrin-dependent internalization, will be blocked 
at 4 °C. Endocytosis is an energy-dependent 
mechanism that is also hindered when incubations 
are carried out in ATP-depleted environments, as 
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attained by incubation with 10 mM sodium azide 
(NaN3). In our experiments (Figure 3 (b) and (c)), 
both incubations at 4 °C and with NaN3 resulted in 
inhibition of uptake of CNT complexes in PC3 cells, 
suggesting an energy-dependent mechanism for 
their internalization 
Pharmacological inhibition of cellular trafficking 
can be achieved with the compound LY294002, 
which is an inhibitor of Phosphoinositide 3-kinase 
(PI-3 kinase). PI-3 kinases are a family of enzymes 
involved in signal transduction and membrane 
trafficking, as well as other molecular processes. 
Trafficking processes that are inhibited by 
LY294002 include translocation to the plasma 
membrane [33, 34], endocytosis [35, 36], endosome 
fusion [31], lysosomal protein sorting [37, 38], 
transcytosis [39] and autophagy [40]. The 
compound 3-methyladenine is a specific inhibitor of 
autophagic sequestration [41] that also inhibits PI-3 
kinase. When either LY294002 or 3-methyladenine 
were employed in our study, we observed a 
blockage of membrane traffic and endosome fusion, 
which prevented CNT complexes from being 
internalized by PC3 cells (Figure 3 (d) and (e)).  
 
 
Figure 3: Effect of inhibitory conditions for endocytic 
uptake. Cells were exposed to 30 µg/mL of oxDWNT-RNA-FS 
for 2 hours and the effects of various (pre)-treatments on CNT 
internalization were studied. (a). incubation at 4 °C (b); 
pre-incubation with sodium azide (NaN3) (c); pre-incubation 
with phosphoinositide 3-kinase inhibitor (LY294002) (d); 
pre-incubation with 3 methyadenine (e). Actin filaments (red) 
were stained with Alexa Fluor® 546 Phalloidin and nuclei (blue) 
with  TO-PRO®-3. 
 
 
3 Conclusions 
The objective of the present study was to elucidate 
the mechanism of uptake of CNTs, as well as to 
determine the intracellular compartments in which 
they localize.  
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From the data presented herein we propose an 
endocytic route for uptake and trafficking of CNT 
complexes (functionalized by means of oxidation 
and wrapping with RNA). Figure 4 schematically 
represents the intermediate stations of CNT 
complexes during their passage through PC3 cells. 
Evidence of their intracellular localization was 
demonstrated by Raman spectroscopy and 
fluorescence spectroscopy of exposed cells. The 
CNT complexes were found to be endocytosed by 
capture in clathrin-coated vesicles as revealed by 
clear co-localization with both clathrin and 
transferrin. These results are in agreement with the 
work reported by Kam et al. [5], who also found 
evidence for clathrin-mediated endocytosis as an 
uptake mechanism for CNTs. Molecules entering 
cells via endocytic pathways will rapidly experience 
a drop in pH from neutral to pH 5.9-6.0 in the 
lumen of early/recycling vesicles with further 
reduction from pH 6.0 to 5.0 during progression 
from late endosomes to lysosomes [32]. In our 
studies, CNT complexes were found in early 
endosomes as confirmed by co-localization with 
early endosome antigen (EEA). CNT complexes 
were not sorted for recycling back to the cell 
membrane (via fast recycling endosomes), as 
co-localization with Rab 4 was not observed; 
instead, co-localization with both LAMP2 antibody 
and LysoTracker® marker indicated their 
sequestration in lysosomes. In addition, CNT 
complexes were also found within Rab11-positive 
vesicles of the secretory pathway.  
Overall, our study brings novel findings on the 
uptake and traffic of CNTs in mammalian cells, 
allowing identification of the uptake pathway and 
the cellular organelles, in which CNTs localize. 
Additionally, exocytosis was once again confirmed 
with additional identification of the key organelle 
responsible for CNTs efflux: it is reported for the 
first time that the recycling endosomes from the 
trans-Golgi network (Rab11-positive vesicles) are 
responsible for extracellular extrusion of CNTs.   
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Figure 4: Proposed intracellular trafficking of CNT complexes. The internalization of oxDWNT-RNA-FS-complexes was proven 
to be energy-dependent as it could be blocked by incubation at 4 °C and pre-incubation with NaN3 (Fig. 3 (b) and (c)). Additionally, 
incubation with PI-3 kinase inhibitors, known to interfere with vesicular trafficking, led to reduced internalization of CNTs (Fig. 3 (d) 
and (e)). Co-localization with both clathrin and transferrin provided evidence for clathrin-mediated endocytosis (Figure 2 (c) and (h)), 
after which CNT complexes undergo sorting in the early endosomes (co-localization with EEA1 – Fig. 2 (d)). CNT complexes are then 
sequestrated in the lysosomes, as confirmed by Lamp2 and LysoTracker® staining (Fig. 2 (f) and (i), respectively). CNTs were also 
found within within vesicles of the secretory pathway (Rab11-positive vesicles), which for the first time suggests an exact route for their 
exocytosis (Fig. 2 (g)).  
 
4 Experimental 
4.1 Preparation of fluorescently labelled 
oxidized DWNTs 
DWNTs synthesized by the CCVD technique[42] 
were purified in concentrated nitric acid and 
oxidized in a mixture of nitric and sulphuric acid 
[43]. In the first step, 100 mg CNTs were 
dispersed in 20 mL concentrated nitric acid, 
sonicated with a tip sonicator (MSE Soniprep 150, 
amplitude 8 µm) 6 times for 10s, and incubated in 
a water bath (Grant ultrasonic bath XB2, Farnell, 
UK) at 95 °C for 2 hours. After oxidation, the acid 
was diluted with water and the mixture 
centrifuged (10 minutes at 50000 g, 4 °C) 
(Beckman Avanti J25, Buckinghamshire, UK), 
followed by thorough washing with distilled 
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water. These pre-treated CNTs were then 
redispersed in a 3:1 mixture of concentrated nitric 
and sulphuric acid and the above described 
process repeated. Afterwards, the oxidized CNTs 
were vacuum-filtered using a 0.2 µm 
polycarbonate filter (Whatman Ltd., UK) until the 
eluate was clear and of neutral pH. The filtrate 
was then sonicated with a tip sonicator 6 times 
for 10s and centrifuged three times at 75000 g to 
remove large agglomerates and CNT bundles. 
The concentration of these dispersions was 
determined gravimetrically and adjusted to 100 
µg/mL for storage in the fridge at 4 °C. After 
oxidation, nanotubes were sterilized by 
autoclaving at 121 °C for 1 hour and were 
maintained under sterile conditions for the 
duration of the experiment. In a second step, the 
oxidized DWNTs (oxDWNTs) were 
biofunctionalized by wrapping with fluorescently 
labelled RNA as described below.  
Biofunctionalization of oxDWNTs with RNA was 
achieved using ready-made fluorescently labelled 
RNA (Eurofins – MWG Operon), with the 
oligonucleotide sequence (5’) 
CAUUCCGAGUGUCCACAUUCCGAGUGUCC
A-FLU (3’) (RNA-FS). The manufacturer details 
states that the oligonucleotide has a molecular 
weight of 10052 g/mol, Tm of 69.5 ºC, GC-content 
of 53.3 % and has been purified by 
High-Performance Liquid Chromatography 
(HPLC). A solution of 1.0 mg/mL (prepared in 
sterile water) was diluted 1:5 in a solution of 
oxDWNTs at a concentration of 200 µg/mL 
(weight ratio CNTs/RNA 1:0.8). After that, the 
complexes were allowed to form by stirring for 2 
hours at room temperature (~21 °C) in the dark. 
To remove unbound RNA-FS, the solution was 
filtered and washed several times using 100 kDa 
centrifugal filters (Millipore). Finally, the 
RNA-fluorescein wrapped oxidized DWNTs 
(oxDWNT-RNA-FS) were resuspended in sterile 
water to a final concentration of 200 µg/mL. 
Samples were characterized by Raman 
spectroscopy, atomic force microscopy (AFM) 
and transmission electron microscopy (TEM). 
Raman spectroscopy was performed for pristine 
DWNTs, oxDWNTs-RNA and cells containing 
oxDWNT-RNA-FS, using a Renishaw InVia 
Raman microscope, Elaser=1.59 eV (785 nm 
wavelength).  For AFM sample preparation, 
oxDWNTs were diluted with water to obtain a 
concentration of 10 µg/mL. A droplet of 2 µL was 
placed onto a freshly cleaved mica substrate (1 
cm2) and dried in air. AFM measurements were 
performed using a PicoPlus instrument (Agilent 
Technologies, Chandler, AZ) operated in contact 
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mode at room temperature with a lateral scan 
rate of 1 - 1.5 Hz at 512 lines. Data analysis was 
carried out using “Gwyddion 2.9”, a free SPM 
data visualization and imaging tool released 
under the GNU General Public License. Samples 
for TEM were prepared by dilution of the sample 
in acetone and placing a single drop of the 
solution on a standard copper grid. High 
resolution TEM measurements were performed 
using a FEI Tecnai G2F20 S Twin instrument with 
an accelerating voltage of 200 kV. 
 
4.2 Cellular incubation with CNTs-complexes 
and compartment staining 
PC3 cells were cultured in RPMI-1640 medium 
supplemented with 10 % FBS, 2mM Glutamax™ 
and 1 % penicillin-streptomycin (all obtained 
from Invitrogen, Paisley, UK). Cells were 
cultured in 24-well (13 mm-well) sterile plates 
(Nunc, Thermo Scientific) containing glass 
coverslips (VWR International, Lutterworth, UK) 
for 24 hours so that they were 50 % confluent at 
the time of exposure to CNT complexes. 
4.2.1 Incubation with inhibitory drugs 
For adenosine triphosphate (ATP) depletion 
studies, a PBS buffer solution supplemented with 
10 mM sodium azide (NaN3) and 50 mM 
D-glucose was diluted as a ratio of 1:2 in 
complete RPMI medium and incubated with cells 
for 2 hour at 37 °C, followed by incubation in a 
solution of CNT complexes. For inhibitory 
conditions with LY294002 (phosphoinositide 
3-kinase inhibitor) and 3-methyladenine 
(inhibitor of autophagic sequestration), cells were 
incubated overnight with 10 µM of drug before 
addition of the CNT complexes.   
4.2.2 Incubation with CNT-complexes 
PC3 cells growing in 24-well plates were 
incubated with 30 µg/mL CNT complexes diluted 
in complete RPMI medium. After incubation for 2 
hours, cells were washed twice with sterile PBS 
(Invitrogen, Paisley, UK) and fresh medium 
added for 5 minutes. Cells were again washed 
with sterile PBS and treated for 10 minutes with 
CellScrub (Genlantis, San Diego, USA) washing 
buffer to remove all extracellular CNT 
complexes. Finally, cells were washed twice more 
with sterile PBS.     
4.2.3 Cell fixation 
To prevent morphological changes and inhibit 
further natural cellular transport, cells were fixed 
with 4 % (w/v) paraformaldehyde (Sigma 
Aldrich, Poole, UK) solution in PBS for 1 hour at 
room temperature. Then cells were washed once 
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more with sterile PBS and treated with 0.1 % v/v 
Triton X-100 (Sigma Aldrich, Poole, UK) in PBS to 
allow permeabilization of cell membranes.   
4.2.4 Compartment staining (using phalloidin, 
TO-PRO®-3, LysoTracker® red & transferrin) 
Cell membrane-associated actin filaments were 
stained using phallotoxins (Alexa Fluor® 555 
Phalloidin – emission 565 nm) with a final 
concentration of 0.044 µM. Transferrin conjugates 
(Alexa Fluor 546 - emission 573 nm) at a 
concentration of 20 µg/mL were applied to stain 
endosomes associated with clathrin-dependent 
endocytosis, and acidic cell compartments 
(lysosomes) were stained using LysoTracker 
Red DND-99 (emission 590 nm) at a final 
concentration of 1 µM. All agents were diluted 
from freshly made stock solutions in 0.5 % bovine 
serum albumin (BSA; Sigma Aldrich) in sterile 
PBS and applied to cells after fixation for a period 
of 15 minutes. Cells were then washed three 
times with PBS and finally, To-Pro-3 (emission 
661 nm), a monomeric cyanine nucleic acid stain, 
was applied in order to visualize the cell nuclei in 
all samples. It was employed as the final step of 
the immunocytochemistry using a concentration 
of 0.1 µM in PBS (all reagents from Invitrogen- 
Molecular Probes Corporation, unless stated 
otherwize).  
4.2.5 Immunostaining  
Subsequent to cell fixation and permeabilization, 
cells were incubated for 90 minutes with primary 
antibodies (Santa Cruz Biotechnology, Inc; 
supplied by Insight Biotechnology; Harrow, UK) 
diluted in PBS containing 0.5 % BSA, as described 
in Table 1. Cells were then washed three times 
with PBS and incubated for 1 hour with 
fluorescent secondary antibody (Alexa Fluor 546 
from Invitrogen) diluted 1:100 in 0.5 % BSA in 
PBS, followed by three 5 minutes washes in PBS. 
After immunostaining, cells were also stained 
with To-Pro-3 as described (above). 
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Table 1: Immunostaining. Primary antibodies employed and respective secondary antibodies. 
Primary antibody Dilution factor for 
primary antibody 
Secondary antibody 
Clathrin HC (H-300): sc-9069 1:100 Anti-Rabbit 
Caveolin-1 (N20): sc-894 1:200 Anti-Rabbit 
Early endosome antigen (EEA1) (C15): sc-6414 1:500 Anti-Goat 
Lysosome-associated membrane proteins (Lamp 2) (H4B4): sc-18822  1:2000 Anti-Mouse 
Ras-related superfamily - Rab 4/14 (FL-213): sc28569  1:200 Anti-Rabbit 
Ras-related superfamily - Rab 11 (H87): sc-9020 1:80 Anti-Rabbit 
 
4.2.6 Mounting glass-slides and microscopy 
Following the final step for all samples, in which 
nucleic acids were stained with To-Pro-3, 
coverslips were removed from the 24-well plate 
using fine forceps and were then held vertically 
against tissue to remove excess liquid. A small 
drop of VECTASHIELD® Mounting Medium 
(Vector Laboratories, UK) was placed on a glass 
slide and the coverslip, cells facing down, was 
positioned on top of the Vectashield drop. After 
removing the excess liquid, coverslips were 
sealed using a standard commercially available 
nail lacquer and allowed to dry.  
Images were captured using 63x magnification 
with a Zeiss LSM 510 inverted confocal 
microscope and analysed using LSM 510 META 
software (Zeiss).  
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Time-series analysis of fluorescently labeled RNA-wrapped oxidized DWNTs in cells. 
An evaluation of CNT accumulation in a particular cellular compartment, the lysosomes, is presented. Cells 
were exposed to CNT complexes for 5, 10, 15, and 30 minutes; and 1 , 2 , 4 , and 6 hours. Subsequently, the 
cells were fixed and the lysosomes were stained with LysoTracker® Red in order to afford visualization by 
confocal microscopy. Figure S-1 shows the accumulation of CNTs in lysosomes at the different time points. 
After only 5 minutes a significant amount of CNTs has already been internalized, with the level of CNTs 
slightly increasing within the next 30 minutes. This can be explained by the fact that CNTs were available in 
excess in the medium, which permits constant uptake and release to take place during the observed period of 
6 hours, leading to a steady-state of the intracellular CNT concentration. At intermediate time points it is 
therefore to be expected to observe CNTs at various intracellular locations: while some are in the process of 
being internalized, others are already being sorted in lysosomes, or exocytosed. After 5 and 10 minutes few 
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CNTs (in green) already seem to co-localize with the stained lysosomes (overlap in yellow). In comparison, a 
much larger amount of CNTs is observed inside the cells after 30 minutes with some degree of co-localization 
between CNT and lysosomes; however, the majority of CNTs appears to be distributed in other cellular 
compartments. For 1, 2, 4 and 6 hour-incubation times a similar situation is observed.  
 
 
 
Figure S-1 – Time-series of cells exposed to oxDWNT-RNA-FS (in green). Lysosomes were counter-stained with LysoTracker® Red 
(in red) and nucleus (blue) stained with TO-PRO®-3. 
 
Plot profile for antibody/CNT overlay. 
To provide further evidence of co-localization of CNTs and various subcellular compartments counterstained 
using specific subcellular markers (antibodies) as presented in Figure 2, the intensity of each dye in the specific 
subcellular regions was evaluated using Image J software. Figure S-2 exhibits a selection of images from Fig. 2 
in which co-localization was observed, including a) clathrin; b) EEA1; c) Lamp2, d) Rab11, f) Transferrin and g) 
LysoTracker®. The graphs in the right columns present the relative intensity for the selected regions within the 
cell (Line 1 and 2). The results confirm the co-localization of CNTs with the following antibodies: clathrin, 
EEA1, Lamp2, Rab11, transferrin and LysoTracker®. 
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Figure S-2 – Fluorescence microscopy of PC3 cells exposed to DWNTs and counter-stained with different antibodies: a) clathrin; b) 
EEA1; c) Lamp2, d) Rab11, f) transferring and g) LysoTracker®. Co-localization profiles of selected regions (Line 1 and 2) are 
presented for each antibody, in which green represents the DWNTs labeled with fluorescein and red the antibody (Alexa Fluor® 
546-labelled).  Nuclei (in blue) were stained with TO-PRO®-3. 
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